Dicerna Pharmaceuticals Inc

NASDAQ:DRNA   12:30:06 PM EDT
38.28
+1.24 (+3.35%)
Products

Dicerna Announces FDA Acceptance Of Lilly’S Investigational New Drug Application For Ly3819469

Published: 05/27/2021 11:44 GMT
Dicerna Pharmaceuticals Inc (DRNA) - Dicerna Announces FDA Acceptance of Lilly’s Investigational New Drug (ind) Application for Ly3819469.